Search Results - "ONUTA, Geanina"

Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency by Onuta, Geanina, van Ark, Joris, Rienstra, Heleen, Boer, Mark Walther, Klatter, Flip A, Bruggeman, Cathrien A, Zeebregts, Clark J, Rozing, Jan, Hillebrands, Jan-Luuk

“…Abstract Objective Transplant vasculopathy consists of neointima formation in graft vasculature resulting from vascular smooth muscle cell recruitment and…”
Get full text

Role of Progenitor Cells in Transplant Arteriosclerosis by Hillebrands, Jan-Luuk, Onuta, Geanina, Rozing, Jan

“…To date, chronic transplant dysfunction (CTD) is recognized as the major cause of transplant loss long term after transplantation. CTD has the remarkable…”
Get full text

Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes by Onuta, Geanina, Westerweel, Peter E., Zandvoort, André, van Riezen, Manon, Rozing, Jan, Hillebrands, Jan-Luuk, Verhaar, Marianne C.

“…Diabetes is associated with impaired neovascularization leading to reduced revascularization of ischemic tissue and impaired wound healing. Endothelial…”
Get full text

Long-Term Type 1 Diabetes Enhances In-Stent Restenosis after Aortic Stenting in Diabetes-Prone BB Rats by Onuta, Geanina, Groenewegen, Hendrik C., Klatter, Flip A., Walther Boer, Mark, Goris, Maaike, van Goor, Harry, Roks, Anton J. M., Rozing, Jan, de Smet, Bart J. G. L., Hillebrands, Jan-Luuk

“…Type 1 diabetic patients have increased risk of developing in-stent restenosis following endovascular stenting. Underlying pathogenetic mechanisms are not…”
Get full text

Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats by ONUTA, Geanina, RIENSTRA, Heleen, FREARK DE BOER, Jan, WALTHER BOER, Mark, ROKS, Anton J. M, KLATTER, Flip A, UGES, Donald R. A, NAVIS, Gerjan, ROZING, Jan, HILLEBRANDS, Jan-Luuk

“…Transplant arteriosclerosis is a leading cause of chronic transplant dysfunction and is characterized by occlusive neointima formation in intragraft arteries…”
Get full text

Dichotomous Effects of Rosiglitazone in Transplantation-Induced Systemic Vasodilator Dysfunction in Rats by ONUTA, Geanina, HILLEBRANDS, Jan-Luuk, RIENSTRA, Heleen, WALTHER BOER, Mark, KLATTER, Flip A, NAVIS, Gerjan, RAZING, Jan, ROKS, Anton J. M

“…Transplantation-induced systemic endothelial dysfunction causes severe cardiovascular morbidity and mortality after transplantation. Interventions that improve…”
Get full text

Rosiglitazone attenuates transplant arteriopathy in rat aortic allografts by Onuta, Geanina, Rienstra, Heleen, de Boer, Jan Freark, Roks, Anton J.M., Klatter, Flip A., Rozing, Jan, Hillebrands, Jan-Luuk

Get full text

Non-bone marrow origin of neointimal smooth muscle cells in experimental in-stent restenosis in rats by Groenewegen, Hendrik C, Onuta, Geanina, Goris, Maaike, Zandvoort, André, Zijlstra, Felix, van Gilst, Wiek H, Rozing, Jan, de Smet, Bart J G L, Roks, Anton J M, Hillebrands, Jan-Luuk

“…To determine the contribution of bone marrow (BM)-derived cells in in-stent restenosis (ISR) and transplant arteriosclerosis (TA). Non-transgenic rats WT…”
Get more information

Cytomegalovirus-enhanced development of transplant arteriosclerosis in the rat; effect of timing of infection and recipient responsiveness by Hillebrands, Jan-Luuk, van Dam, Joanne G, Onuta, Geanina, Klatter, Flip A, Grauls, Gert, Bruggeman, Cathrien A, Rozing, Jan

“…Cytomegalovirus (CMV) is put forward as a risk factor for transplant arteriosclerosis (TA). In this article, we studied CMV-enhanced development of TA in rats…”
Get more information

Circulating smooth muscle cell plasticity in the development of transplant arteriosclerosis by Hillebrands, Jan-Luuk, Onuta, Geanina, Klatter, Flip, Rozing, Jan

“…To date, chronic transplant dysfunction (CTD) is recognized as the major cause of long-term transplant loss (>1 year) after transplantation. CTD presents…”
Get full text

Long-Term Type 1 Diabetes Enhances In-Stent Restenosis after Aortic Stenting in Diabetes-Prone BB Rats by Onuta, Geanina, Groenewegen, Hendrik C., Klatter, Flip A., Walther Boer, Mark, Goris, Maaike, van Goor, Harry, Roks, Anton J. M., Rozing, Jan, de Smet, Bart J. G. L., Hillebrands, Jan-Luuk

“…Type 1 diabetic patients have increased risk of developing in-stent restenosis following endovascular stenting. Underlying pathogenetic mechanisms are not…”
Get full text